The goal of this study is to understand why some people receiving chimeric antigen receptor (CAR) T-cell therapy for cancer experience neurotoxicity. The main …

CAR T-Cell Therapy

~Estimated

~$10 – $750

University of California, San DiegoNCT07075523

Phase 1

Exercise-induced Adrenergic Receptor Signaling as an Immune Adjuvant for Allogeneic Cell Therapies

This study aims to improve the treatment of blood cancer by using exercise to collect healthier immune cells from donors. Allogeneic adoptive cell therapy is a…

LeukemiaHematopoetic Stem Cell TransplantationDonor Lymphocyte Infusion+3 more

~Estimated

~$10 – $6,250

University of ArizonaNCT06643221

Observational

Randomized Controlled Trial of a Supportive Care Digital Application (THRIVE-CAR-T) for Patients Receiving CAR-T Cell Therapy

The goal of this clinical trial is to learn if a digital mobile application called THRIVE-CAR-T is helpful for the care of patients undergoing CAR-T cell thera…

CAR T-Cell Therapy

~Estimated

~$10 – $7,500

Patrick C. Johnson, MDNCT06665295